Keating Financial Advisory Services’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Keating Financial Advisory Services's JAZZ Position: Q2 2026 in Review
Keating Financial Advisory Services increased its Jazz Pharmaceuticals (JAZZ) stake by 15% in Q2 2026, buying an estimated $1.75K and bringing the position to 63 shares worth $15.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1085.
Keating Financial Advisory Services first reported a position in JAZZ in Q4 2025 and has held it in 3 quarters since. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Keating Financial Advisory Services held 63 shares of Jazz Pharmaceuticals worth $15.2K as of Q2 2026.
- Keating Financial Advisory Services bought 8 Jazz Pharmaceuticals shares in Q2 2026, an estimated $1.75K.
- Jazz Pharmaceuticals made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #1085 holding.
- Keating Financial Advisory Services first reported a position in Jazz Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.